Detalles de la búsqueda
1.
Multivariate time-dependent comparison of the impact of lenalidomide in lower-risk myelodysplastic syndromes with chromosome 5q deletion.
Br J Haematol
; 166(2): 189-201, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24716538
2.
Clonal genetic evolution at relapse of favorable-risk acute myeloid leukemia with NPM1 mutation is associated with phenotypic changes and worse outcomes.
Haematologica
; 103(9): e400-e403, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29622659
3.
No Evidence that CD33 rs12459419 Polymorphism Predicts Gemtuzumab Ozogamicin Response in Consolidation Treatment of Acute Myeloid Leukemia Patients: Experience of the PETHEMA Group.
Dis Markers
; 2022: 3132941, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36051360
4.
Long-Term Outcomes After Autologous Versus Allogeneic Stem Cell Transplantation in Molecularly-Stratified Patients With Intermediate Cytogenetic Risk Acute Myeloid Leukemia: A PETHEMA Study.
Transplant Cell Ther
; 27(4): 311.e1-311.e10, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33836871
5.
Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study.
Leuk Res
; 92: 106352, 2020 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-32240863
6.
Corrigendum to "Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study" [Leuk. Res. 92 (March) (2020) 106352].
Leuk Res
; 96: 106388, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32680618
Resultados
1 -
6
de 6
1
Próxima >
>>